← Back to Clinical Trials
Recruiting NCT06526325

NCT06526325 The Effect of Tendon Release Techniques in Patients With Cervical Disc Herniation

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06526325
Status Recruiting
Phase
Sponsor Istanbul Arel University
Condition Cervical Disc Herniation
Study Type INTERVENTIONAL
Enrollment 51 participants
Start Date 2024-02-19
Primary Completion 2024-08

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 65 Years
Study Type INTERVENTIONAL
Interventions
Enhanced golgi tendon organ stimulation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 51 participants in total. It began in 2024-02-19 with a primary completion date of 2024-08.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this clinical trial is to investigate the effect of using enhanced golgi tendon organ stimulation on symptoms in patients with cervical disc herniation. The main question\[s\] it aims to answer are: * Enhanced Golgi tendon organ stimulation is effective in reducing symptoms in patients with cervical disc herniation. * Enhanced golgi tendon organ stimulation is not effective in reducing symptoms in patients with cervical disc herniation. Participants will receive enhanced golgi tendon organ stimulation to the Sternocleidomastoideus, platysma, longus colli, longus capitis, scalene, rhomboid major \& minor, levator scapulae and trapezius muscles for 3 weeks, 2 sessions per week for 45 minutes.

Eligibility Criteria

Inclusion Criteria: * Being diagnosed with cervical disc herniation * Volunteering for the research Exclusion Criteria: * Chronic bone disease * Have had surgery for a cervical disc herniation * Have a structural abnormality

Contact & Investigator

Central Contact

hasan aslan

✉ asfizyoterapi@gmail.com

📞 +905538073527

Principal Investigator

hasan aslan

PRINCIPAL INVESTIGATOR

AS Physiotherapy Services centre

Frequently Asked Questions

Who can join the NCT06526325 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Cervical Disc Herniation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06526325 currently recruiting?

Yes, NCT06526325 is actively recruiting participants. Contact the research team at asfizyoterapi@gmail.com for enrollment information.

Where is the NCT06526325 trial being conducted?

This trial is being conducted at Istanbul, Turkey (Türkiye).

Who is sponsoring the NCT06526325 clinical trial?

NCT06526325 is sponsored by Istanbul Arel University. The principal investigator is hasan aslan at AS Physiotherapy Services centre. The trial plans to enroll 51 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology